Cardiometabolic Benefits and Risks of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitor and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review
钠-葡萄糖协同转运蛋白2 (SGLT-2) 抑制剂与胰高血糖素样肽-1 (GLP-1) 受体激动剂联合治疗2型糖尿病的心血管代谢获益和风险:系统评价
期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.96218
Tantawy, Dalia; Musa Rabih, Maram Rabih; Ibrahim Mohamed, Razan Seifeldin; Abdelrahman Ali, Malaz Omer; Mohammed Saad Aldeen, Rayan Saad Aldeen; Ahmed Abdelkarim, Ali Omer; Awadalkreem Mohamedzain, Tawasul Greeballah